Login

Anders Rabbe, CEO, Isofol Medical AB (publ) 00:00:00

Share On Facebook Share On Twitter

Isofol Medical at Pareto Securities' Health Care Conference

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Aarhus Physics APS: Advancing Geophysical Consulting with Airborne Electromagnetic Technology
00:10:00
Breaking Chains: Finding Success and Happiness
00:10:00
Evergrande's Debt Crisis: A Ticking Domino for China's Economy
00:10:00
Akari Therapeutics' Innovative Approach to Treating Rare Hematopoietic Stem Cell Transplant Complications| Rachelle Jacques, CEO, Akari Therapeutics PLC.
00:10:00
Investing In What’s Important is a series featuring EP Wealth Advisors' team, where Derek Holman, CFP®, AIF, discusses the benefits of the fee-only approach and its impact on clients, especially small business owners and executives.
00:10:00
"Aamal Company's CEO, Mr. Rashid Al Mansoori, discusses the company's innovative strategies for sustainable growth and community development on Qatar Television."| Mr. Rashid Al Mansoori CEO of Aamal Company
00:10:00
From Academia to Executive Leadership: An Inside Look at Career Evolution and Diversity Initiatives | Hanneke Smits, CEO , The Bank of New York Mellon Corporation.
00:10:00
Aspen Group: Navigating the Affordable Accommodation Sector Amidst Economic Shifts|CEO , Aspen Group Ltd
00:10:00
Goldman Sachs 2020 Investor Day: Strategic Priorities and Shareholder Value Focus
00:10:00
globally invests exclusively in early stage COSS|Joseph Jacks,General Partner,OSS Capital LP
00:10:00
Dennis Calvert Outlines BioLargo's Vision and Milestones Ahead of Strategic Investment Insights Chicago | Dennis Calvert , CEO, BioLargo Inc.
00:10:00
to invest in advanced technologies with the potential to solve coming challenges|Andrew Chung,Managing Partner,1955 Capital

© 2026 Nehu